《新股消息》时代天使(06699.HK)首日招股暂录孖展1,105亿元 超购约378倍
内地隐形矫治服务商时代天使(06699.HK)首日招股,截至下午约2时半已录得逾1,105亿元孖展认购,其中富途借出350亿元,辉立则借出200亿元。以公开发售部分集资2.91亿元计,超额认购约378.7倍。
早前有外电消息指,其国际配售部分於首个小时已录得足额认购。
时代天使今次将发行共1,682.96万股,当中1,514.66万股为国际部分,占90%,其余10%即168.3万股为本地公开发售,另设15%超额配售权。招股书列明,若公开发售录得超额认购100倍或以上,公开发售部分占比将重新分配至50%,即841.48万股。
时代天使的招股期至下周二(8日)结束,料於16日上市,每手200股,入场费达34,948.66元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.